Circulating prolactin levels and risk of epithelial ovarian cancer.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3602319)

Published in Cancer Causes Control on February 03, 2013

Authors

Tess V Clendenen1, Alan A Arslan, Anna E Lokshin, Mengling Liu, Eva Lundin, Karen L Koenig, Franco Berrino, Goran Hallmans, Annika Idahl, Vittorio Krogh, Annekatrin Lukanova, Adele Marrangoni, Paola Muti, Brian M Nolen, Nina Ohlson, Roy E Shore, Sabina Sieri, Anne Zeleniuch-Jacquotte

Author Affiliations

1: Department of Population Health, New York University School of Medicine, New York, NY, USA. tess.clendenen@nyumc.org

Articles cited by this

Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res (2007) 11.09

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18

Prolactin: structure, function, and regulation of secretion. Physiol Rev (2000) 4.95

Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev (1995) 3.70

Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A (2005) 3.22

Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev (2006) 2.14

Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res (2009) 1.73

Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst (1985) 1.60

Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting. Obstet Gynecol (1990) 1.55

Prolactin and breast cancer risk. Med J Aust (1990) 1.52

Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control (1995) 1.48

The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci (2011) 1.47

Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.44

Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med (1987) 1.37

Structural variants of prolactin: occurrence and physiological significance. Endocr Rev (1995) 1.21

Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev (1996) 1.14

Biological significance of prolactin in gynecologic cancers. Cancer Res (2009) 1.13

Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer (2007) 1.11

Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol (1977) 1.09

The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol (1988) 1.05

Comparison of candidate serologic markers for type I and type II ovarian cancer. Gynecol Oncol (2011) 0.97

Reliability of serum prolactin measurements in women. Cancer Epidemiol Biomarkers Prev (1993) 0.97

The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. Eur J Cancer Clin Oncol (1987) 0.96

Reproducibility of serum pituitary hormones in women. Cancer Epidemiol Biomarkers Prev (2008) 0.95

Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Reproduction (2010) 0.94

Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology (2011) 0.93

Variation of female prolactin levels with menopausal status and phase of menstrual cycle. Aust N Z J Obstet Gynaecol (2011) 0.92

Associations of body size and reproductive factors with circulating levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Causes Control (2011) 0.91

Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance. J Endocrinol Invest (1993) 0.91

Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med (1975) 0.89

Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland. Br J Cancer (2010) 0.89

Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patients. Eur J Cancer Prev (1997) 0.88

Prolactin pulsatile characteristics in postmenopausal women. J Clin Endocrinol Metab (1998) 0.87

Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth. Int J Cancer (1981) 0.87

Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists. Cancer Lett (2011) 0.87

Prolactin signaling mechanisms in ovary. Mol Cell Endocrinol (2011) 0.86

Elevated levels of prolactin in nulliparous women. Br J Cancer (1981) 0.86

Plasma hormone profiles of young women at risk for familial breast cancer. Cancer Res (1978) 0.86

Prolactin inhibits apoptosis of ovarian carcinoma cells induced by serum starvation or cisplatin treatment. Int J Cancer (2005) 0.86

Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst (1986) 0.85

Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2007) 0.85

Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice. Biol Reprod (2008) 0.84

Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil Steril (1997) 0.84

Evaluation of serum prolactin levels in patients with endometriosis and infertility. Gynecol Obstet Invest (1999) 0.83

Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression. J Clin Endocrinol Metab (1981) 0.83

Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer. Cancer (1991) 0.80

Elevated bioactive prolactin in women at risk for familial breast cancer. Eur J Cancer Clin Oncol (1985) 0.79

Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. Biol Reprod (1985) 0.79

Nyctohemeral changes in plasma prolactin levels and their relationship to breast cancer risk. Int J Cancer (1984) 0.78

Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment. Oncology (1980) 0.77

Articles by these authors

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008) 7.18

Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol (2013) 6.12

Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99

Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet (2004) 5.64

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev (2002) 5.34

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst (2005) 4.45

Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17

Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2010) 3.98

Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer (2003) 3.89

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet (2003) 3.53

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51

Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ (2005) 3.48

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41

Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. JAMA (2013) 3.40

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One (2008) 3.36

Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ (2011) 3.34

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood (2010) 3.21

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06

Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot (2006) 3.03

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03

Consumption of vegetables and fruits and risk of breast cancer. JAMA (2005) 3.02

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96

Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer (2004) 2.96

Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2009) 2.93

Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.90

Prospective study of hyperglycemia and cancer risk. Diabetes Care (2007) 2.89

Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer (2006) 2.89

Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol (2003) 2.79

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med (2008) 2.79

Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76

Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta (2006) 2.76

Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol (2010) 2.71

Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ (2010) 2.66

Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63

Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst (2008) 2.61

Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer (2002) 2.60

Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60

Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol (2009) 2.56

Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2005) 2.53

Work-related musculoskeletal disorders in physical therapists: a prospective cohort study with 1-year follow-up. Phys Ther (2008) 2.53

Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51

Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ (2010) 2.50

Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 2.47

Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev (2002) 2.42

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer (2005) 2.32

Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol (2002) 2.19

Air pollution and risk of lung cancer in a prospective study in Europe. Int J Cancer (2006) 2.17

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b. Clin Cancer Res (2007) 2.15

Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care (2010) 2.14

Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes Control (2007) 2.08

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res (2004) 2.03

Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol (2005) 2.02

N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort. Cancer Epidemiol Biomarkers Prev (2013) 2.01

Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer (2006) 2.00

Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev (2009) 1.99

Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr (2012) 1.98

Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res (2011) 1.98

Relationship of alcohol drinking pattern to risk of hypertension: a population-based study. Hypertension (2004) 1.97

Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96

Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95

Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ (2011) 1.94

Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91

Obesity and colon cancer: does leptin provide a link? Int J Cancer (2004) 1.89

Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88

Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol (2009) 1.87

The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer (2010) 1.86

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85

Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study1,4. Am J Clin Nutr (2013) 1.84

Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med (2009) 1.83